BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23608445)

  • 1. Antiangiogenic and antiapoptotic treatment in advanced melanoma.
    Nikolaou V; Stratigos A; Bafaloukos D; Katsambas A
    Clin Dermatol; 2013; 31(3):257-63. PubMed ID: 23608445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for non-immunological molecular therapeutics in melanoma.
    Eustace AJ; Mahgoub T; Tryfonopoulos D; O'Donovan N; Crown J
    J BUON; 2010; 15(1):9-18. PubMed ID: 20414921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis in melanoma.
    Marneros AG
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecularly targeted therapy for melanoma: current reality and future options.
    Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
    Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
    Kirkwood JM; Gonzalez R; Reintgen D; Clingan PR; McWilliams RR; de Alwis DP; Zimmermann A; Brown MP; Ilaria RL; Millward MJ
    Cancer; 2011 Oct; 117(20):4732-9. PubMed ID: 21456002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma.
    Hersey P
    Curr Opin Oncol; 2006 Mar; 18(2):189-96. PubMed ID: 16462190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapies in melanoma.
    Queirolo P; Acquati M
    Cancer Treat Rev; 2006 Nov; 32(7):524-31. PubMed ID: 17008014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targets in melanoma from angiogenesis to apoptosis.
    Sosman JA; Puzanov I
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2376s-2383s. PubMed ID: 16609062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
    Lorigan P; Eisen T; Hauschild A
    Exp Dermatol; 2008 May; 17(5):383-94. PubMed ID: 18312390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized therapy of disseminated cancer using malignant melanoma as a model.
    Hauschild A; Egberts F; Russo P; Kähler KC
    Cancer Metastasis Rev; 2006 Jun; 25(2):253-6. PubMed ID: 16770537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of metastatic melanoma.
    Tawbi HA; Kirkwood JM
    Semin Oncol; 2007 Dec; 34(6):532-45. PubMed ID: 18083377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel treatment strategies for malignant melanoma: a new beginning?
    Kasper B; D'Hondt V; Vereecken P; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species may have antitumor activity in metastatic melanoma.
    Tuma RS
    J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
    [No Abstract]   [Full Text] [Related]  

  • 14. New approaches in metastatic melanoma: biological and molecular targeted therapies.
    Lejeune FJ; Rimoldi D; Speiser D
    Expert Rev Anticancer Ther; 2007 May; 7(5):701-13. PubMed ID: 17492933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The systemic treatment of advanced cutaneous melanoma.
    Logan TF
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
    [No Abstract]   [Full Text] [Related]  

  • 16. Fotemustine for the treatment of melanoma.
    Quéreux G; Dréno B
    Expert Opin Pharmacother; 2011 Dec; 12(18):2891-904. PubMed ID: 22077794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF, a target in melanoma: implications for solid tumor drug development.
    Flaherty KT; McArthur G
    Cancer; 2010 Nov; 116(21):4902-13. PubMed ID: 20629085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [To outwit melanoma with its own tricks].
    Bischoff A
    MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
    [No Abstract]   [Full Text] [Related]  

  • 19. New molecular targets in melanoma.
    Flaherty KT
    Curr Opin Oncol; 2004 Mar; 16(2):150-4. PubMed ID: 15075908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic targets in melanoma.
    Martí RM; Sorolla A; Yeramian A
    Actas Dermosifiliogr; 2012 Sep; 103(7):579-90. PubMed ID: 22261672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.